Arrowhead Pharmaceuticals, Inc.
2020 Q2 - 2025 Q3 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q3 | 12/15/2025 | 3,104 | 0.0% | 90,000 | 9/30/2025 |
| 2025 Q2 | 8/18/2025 | 4,108 | 0.0% | 260,000 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 2,715 | 0.0% | 213,130 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 3,290 | 0.0% | 175,000 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 4,261 | 0.0% | 220,000 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 4,678 | 0.0% | 180,000 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 3,861 | 0.0% | 135,000 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 7,399 | 0.1% | 241,807 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 4,299 | 0.0% | 160,000 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 4,012 | 0.0% | 112,500 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 3,747 | 0.0% | 147,500 | 3/31/2023 |
| 2022 Q1 | 5/16/2022 | 1,545 | 0.0% | 33,584 | 3/31/2022 |
| 2020 Q2 | 8/12/2020 | 1,511 | 0.0% | 35,000 | 6/30/2020 |